Figure1 (Image 05)
Guanfacine Tablet, Extended Release
Product Images NDC 63629-8203
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 63629-8203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Image 06)
Figure 3 (Image 07)
Label (Lbl636298203)
This is a description of a drug called Guanfacine Hydrochloride, which comes in the form of tablets containing 2mg of the active ingredient. The tablets are sold under the brand name VSN #0516 YO. The product is intended for prescription use only and should be kept out of the reach of children. It should be stored at temperatures between 20° to 25° Celsius, with excursions allowed to 15° to 30° C. The instructions mention that each tablet is designed to help alleviate hypertension. The product label also includes an NDC number and the drug's manufacturer, but further details on the drug's indications, precautions, and side effects are not available.*
Spl-guanfacine-figure 4 (Spl Guanfacine Figure 4)
This text represents a chart showing the percentage of treatment fare for a placebo and SPD503 (a potential treatment) over the course of 196 days. The treatment fare for the placebo is 100%, while the treatment fare for SPD503 is not specified. The chart also includes information on the time period of the study, which is 196 days, and includes specific days on which data was collected.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
